¼¼°èÀÇ ½Å°æ°è Áúȯ Áø´Ü Ä¡·á ½ÃÀå : ¿¹Ãø(2025-2030³â)
Neurological Disorder Diagnostics Treatment Market - Forecasts from 2025 to 2030
»óǰÄÚµå : 1649460
¸®¼­Ä¡»ç : Knowledge Sourcing Intelligence
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 148 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,950 £Ü 5,559,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,550 £Ü 6,404,000
PDF (Multiple User License) help
PDF º¸°í¼­¸¦ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,782,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

½Å°æ°è Áúȯ Áø´Ü Ä¡·á ½ÃÀåÀº CAGR 5.68%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, ½ÃÀå ±Ô¸ð´Â 2025³â 143¾ï 4,000¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 189¾ï 300¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½Å°æ°è ÁúȯÀº ³ú, ô¼ö ¹× ½Å°æÀ» Æ÷ÇÔÇÑ ½Å°æ°èÀÇ ±â´É¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â Áúº´ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Áúȯ¿¡´Â ¾ËÃ÷ÇÏÀ̸Ӻ´°ú ÆÄŲ½¼º´°ú °°Àº ½Å°æÅðÇ༺ Áúȯ, ±ÙÀÌ¿µ¾çÁõ ¹× ±ÙÀ§Ã༺ Ãø»ö°æÈ­Áõ°ú °°Àº ½Å°æ±ÙÁúȯ, À̺ÐôÃß ¹× ô¼ö ¼Õ»ó°ú °°Àº ôÃß Áúȯ, ¸»ÃÊ ½Å°æ Àå¾Ö ¹× ¼ö±Ù°ü ÁõÈıº°ú °°Àº ¸»ÃÊ ½Å°æ ¹®Á¦¿Í °°Àº ´Ù¾çÇÑ Áúº´ÀÌ Æ÷ÇԵ˴ϴÙ. ½Å°æ°è Áúȯ Áø´Ü ½ÃÀå¿¡´Â ÀÌ·¯ÇÑ Áúº´À» Áø´ÜÇÏ´Â µ¥ »ç¿ëµÇ´Â ¸ðµç µµ±¸, ±â¼ú, Àåºñ, Á¦Ç° ¹× ¼­ºñ½º°¡ Æ÷ÇԵ˴ϴÙ. ¿©±â¿¡´Â Àڱ⠰ø¸í ¿µ»ó¹ý(MRI), ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ¹ý(CT), ½Å°æ ¿µ»ó ¹ÙÀÌ¿À¸¶Ä¿, ÃÊÀ½ÆÄ ½Ã½ºÅÛ, ¹ÙÀÌ¿À¸¶Ä¿¿ë Ç÷¾× ¹× ³úô¼ö¾× °Ë»ç, À¯ÀüÀÚ °Ë»ç, µ¥ÀÌÅÍ ºÐ¼®¿ë ¿þ¾î·¯ºí ±â±â µîÀÇ ±â¼úÀÌ Æ÷ÇԵ˴ϴÙ. ½Å°æ°è Áúȯ Áø´Ü ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÏ´Â ¸î °¡Áö ¿äÀÎÀÌ ÀÖ½À´Ï´Ù. ¾ËÃ÷ÇÏÀ̸Ӻ´, Ä¡¸Å, ÆÄŲ½¼º´ µî ½Å°æÁúȯÀÇ À¯º´·üÀÌ »ó½ÂÇϰí ÀÖ´Â °ÍÀÌ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ »ç°í·Î ÀÎÇÑ ³ú¼Õ»ó Áõ°¡´Â ½ÃÀå ¼ö¿ä¸¦ ´õ¿í ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. ½Å°æÇÐÀû °Ç°­ÀÇ Á¶±â ½ºÅ©¸®´×ÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̱â À§ÇÑ Á¤ºÎ, NGO, ±â°üÀÇ ³ë·Âµµ Á¶±â Áø´Ü ¼ö¿ä¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡´Â Áø´Ü ±â¼ú°ú ÇÁ·Î¼¼½ºÀÇ Áøº¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´× ±â¼úÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ º¸´Ù Á¤È®ÇÑ µ¥ÀÌÅÍ ºÐ¼®À» Á¦°øÇÔÀ¸·Î½á ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ½ÅÈï±¹À» Áß½ÉÀ¸·Î ÇÑ °¢±¹ Á¤ºÎ¿¡ ÀÇÇÑ ÇコÄɾî ÅõÀÚ Áõ°¡°¡ ½ÃÀå È®´ë¸¦ ´õ¿í µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

½Å°æ°è Áúȯ Áø´Ü ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ :

½Å°æ°è Áúȯ Áø´Ü ½ÃÀåÀ» Çü¼ºÇÏ´Â Áö¸®Àû µ¿Çâ :

¿¹¸¦ µé¾î Áß±¹¿¡¼­´Â 2022³â¿¡ ¾à 480¸¸ ¸íÀÌ »õ·Ó°Ô ¾ÏÀ» ¹ßº´ÇØ 257¸¸ ¸íÀÌ »ç¸ÁÇÑ °ÍÀ¸·Î Æò°¡µÇ¾ú½À´Ï´Ù. À̰ÍÀº Áøº¸µÈ Áø´Ü ±â¼úÀ» ÅëÇÑ °³ÀÎÈ­µÈ ÀÇ·á °³¹ßÀÇ Áß¿äÇÑ Çʿ伺À» µ¸º¸ÀÌ°Ô ÇÕ´Ï´Ù. ÇÑÆí, ºÏ¹Ì´Â ÷´Ü °Ç°­ °ü¸® ÀÎÇÁ¶ó·Î ÀÎÇØ ½Å°æ°è Áúȯ Áø´Ü ½ÃÀå¿¡¼­ Å« Á¡À¯À²À» À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½Å°æ ÁúȯÀÇ À¯º´·üÀÇ ³ôÀ̰¡ ÀÌ ¿ìÀ§¼º¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿¹Ãø¿¡ µû¸£¸é 2024³â¿¡´Â ¾ËÃ÷ÇÏÀ̸Ӻ´¿¡ ÀÇÇÑ Ä¡¸Å ȯÀÚ°¡ 690¸¸ ¸í¿¡ ´ÞÇß½À´Ï´Ù. Á¾ÇÕÇÏ¸é ¼¼°èÀÇ ½Å°æ°è Áúȯ Áø´Ü ½ÃÀåÀº ½Å°æ°è ÁúȯÀÇ À¯º´·ü »ó½Â, Á¶±âÁø´Ü¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡, Áø´Ü Åø°ú Áø´Ü °úÁ¤ÀÇ ±â¼úÀû Áøº¸, ÇコÄɾî ÅõÀÚ¿¡ À־ÀÇ Á¤ºÎÀÇ Áö¿øÀû ÀÌ´Ï¼ÅÆ¼ºê, ±×¸®°í ÀÌ È®´ëµÇ´Â ½ÃÀå ȯ°æÀ» °­È­ÇÏ´Â À¯¸®ÇÑ ½ÃÀå µ¿Çâ(ƯÈ÷ ¾Æ½Ã¾ÆÅÂÆò¾ç)¿¡ °ßÀÎµÇ¾î °­·ÂÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¸¦ ±¸ÀÔÇÏ´Â ÀÌÀ¯

¾î¶² ¿ëµµ·Î »ç¿ëµË´Ï±î?

¾÷°è ¹× ½ÃÀå ÀλçÀÌÆ®, »ç¾÷ ±âȸ Æò°¡, Á¦Ç° ¼ö¿ä ¿¹Ãø, ½ÃÀå ÁøÃâ Àü·«, Áö¸®Àû È®´ë, ¼³ºñ ÅõÀÚ °áÁ¤, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© ¹× ¿µÇâ, ½ÅÁ¦Ç° °³Ã´, °æÀïÀÇ ¿µÇâ

Á¶»ç ¹üÀ§

½Å°æ°è Áúȯ Áø´Ü Ä¡·á ½ÃÀåÀº ´ÙÀ½°ú °°ÀÌ ±¸ºÐµË´Ï´Ù.

Áúº´ À¯Çüº°

±â¼úº°

ÃÖÁ¾ »ç¿ëÀÚº°

Áö¿ªº°

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

Á¦5Àå ½Å°æ°è Áúȯ Áø´Ü Ä¡·á ½ÃÀå : Áúȯ À¯Çüº°

Á¦6Àå ½Å°æ°è Áúȯ Áø´Ü Ä¡·á ½ÃÀå : ±â¼úº°

Á¦7Àå ½Å°æ°è Áúȯ Áø´Ü Ä¡·á ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦8Àå ½Å°æ°è Áúȯ Áø´Ü Ä¡·á ½ÃÀå : Áö¿ªº°

Á¦9Àå °æÀï ȯ°æ ¹× ºÐ¼®

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The neurological disorder diagnostics treatment market is expected to grow at a CAGR of 5.68%, reaching a market size of US$18.903 billion in 2030 from US$14.340 billion in 2025

Neurological disorders are conditions that impact the functioning of the nervous system, including the brain, spinal cord, and nerves. These disorders encompass a range of conditions, such as neurodegenerative diseases like Alzheimer's and Parkinson's disease, neuromuscular disorders like muscular dystrophy and amyotrophic lateral sclerosis, spine conditions such as spina bifida and spinal cord injuries, as well as peripheral nerve issues like peripheral neuropathy and carpal tunnel syndrome.The neurological disorder diagnostics market includes all tools, techniques, devices, products, and services used to diagnose these conditions. This encompasses technologies such as magnetic resonance imaging (MRI), computed tomography (CT), neuroimaging biomarkers, ultrasound systems, blood and cerebrospinal fluid tests for biomarkers, genetic testing, and wearable devices for data analysis. Key settings for these diagnostics include hospitals, clinics, and diagnostic centers.Several factors are driving the growth of the neurological disorder diagnostics market. The rising prevalence of neurological diseases such as Alzheimer's, dementia, and Parkinson's disease is a significant contributor. Additionally, the increasing number of brain injuries due to accidents further boosts market demand. Efforts by governments, NGOs, and institutions to raise awareness about the importance of early screening for neurological health are also propelling demand for early diagnosis. Furthermore, increased investment in research and development has led to advancements in diagnostic technologies and processes. The growing adoption of artificial intelligence (AI) and machine learning technologies enhances market growth by providing more accurate data analysis. Additionally, rising healthcare investments by governments-particularly in emerging countries-are further fueling market expansion.

Drivers of the Neurological Disorder Diagnostics Market:

Geographical Trends Shaping the Neurological Disorder Diagnostics Market:

For instance, it was estimated that around 4.8 million new cancer cases and 2.57 million cancer deaths occurred in China in 2022. This highlights the critical need for personalized medicine development through advanced diagnostic technologies.Meanwhile, North America is expected to maintain a significant share of the neurological disorder diagnostics market due to its advanced healthcare infrastructure. The high prevalence of neurological disorders contributes to this dominance; projections indicate that there will be 6.9 million dementia patients due to Alzheimer's in 2024. Additionally, government investments and private sector initiatives are driving continued regional expansion.In summary, the neurological disorder diagnostics market is experiencing robust growth driven by rising prevalence of neurological disorders globally, increased awareness about early diagnosis, technological advancements in diagnostic tools and processes, supportive governmental initiatives in healthcare investment, and favorable geographical trends-particularly within Asia-Pacific-that enhance this expanding market landscape.

Reasons for buying this report:-

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

The Neurological Disorder Diagnostics Treatment Market has been segmented as following:

By Type of Disorder

By Technology

By End-User

By Geography

TABLE OF CONTENTS

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

5. NEUROLOGICAL DISORDER DIAGNOSTICS TREATMENT MARKET BY TYPE OF DISORDER

6. NEUROLOGICAL DISORDER DIAGNOSTICS TREATMENT MARKET BY TECHNOLOGY

7. NEUROLOGICAL DISORDER DIAGNOSTICS TREATMENT MARKET BY END-USER

8. NEUROLOGICAL DISORDER DIAGNOSTICS TREATMENT MARKET BY GEOGRAPHY

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

10. COMPANY PROFILES

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â